L. Arfors et al., PREVALENCE OF ANTIBODIES TO CARDIOLIPIN IN CHRONIC ITP AND REACTIVITYWITH PLATELET MEMBRANES, European journal of haematology, 56(4), 1996, pp. 230-234
Anti-cardiolipin antibodies (ACLA) have been suggested to play a role
in the pathogenesis of thrombocytopenia. When sera from 40 patients wi
th chronic idiopathic thrombocytopenic purpura (ITP) were analyzed for
AC LA, these autoantibodies were present in 12 (30%). In 4 sera the a
ntibody activity was restricted to the IgG or IgM isotype, respectivel
y, while 4 of the samples contained both Ige and IgM antibodies. To el
ucidate the interaction between platelets and ACLA, we studied the rea
ctivity of sera from non-ITP patients with ACLA, with fragmented plate
let membranes. None of them had a concurrent platelet deficiency, but
sera from 8 (67%) of them showed increased IgG-binding to platelet mem
branes. Absorbtion with cardiolipin reduced membrane binding in 6 (50%
). C3 levels were normal, while low C4 values occurred in both groups
with significantly lower levels in ACLA-positive patients (p<0.05). Ci
rculating immune complexes (CIC) were common in both groups. Conclusio
n: The prevalence of ACLA is increased in ITP and sera from non-ITP pa
tients with ACLA react with fragmented platelet membranes. This reacti
vity is often decreased by absorption with cardiolipin, suggesting tha
t ACLA bind to phospholipid epitopes on platelet membranes.